First, a bacterial reverse mutation test (Ames test) assessed AOD9604s mutagenic potential using four histidine-dependent auxotrophic mutants of Salmonella typhimurium (TA1535, TA1537, TA98, TA100) and one tryptophan-dependent auxotrophic mutant of Escherichia coli (WP2 uvrA), using both plate incorporation and pre-incubation methods at doses of 0, 1.6, 8, 40, 200, 1,000, and 2,000 g AOD9604/plate
The most common dose for treating deficiency is 1,000 mcg
The NHS notes that specific symptoms, such as nerve issues like tingling or numbness, can also influence the frequency of your B12 treatment
Skin alterations can indicate underlying issues, such as an allergic reaction or infection, that need to be promptly addressed